CAPA - What does the FDA expect from Medical Devices Manufacturers?

Recommendation
27/28 May 2025
Supervision of the Pharmaceutical Quality System: Challenges and Opportunities
Deficiencies with regard to CAPA (Corrective and Preventive Action) are regularly Top 1 in FDA's Warning Letter statistics (see our GMP News from 23 September 2014). The FDA has just recently published presentations in form of webinars on the following topics:
- Investigational Device Exemption (IDE) Program
- 510(k) Program
- Corrective and Preventive Actions (CAPA)
- Electronic Medical Device Reporting (eMDR)
The 31 slides on CAPA are particularly interesting and aim to:
- Explain the objective of CAPA
- Differentiate individual terms like Correction, Corrective Action, Preventive Action
- Clarify the requirements from the Quality System Regulations 21 CFR 820 (GMP for Medical Devices)
- Present diverse "Tools"
and
- Show examples and "Best Practices"
There is even the possibility to have a look at the webinar's slides "Corrective and Preventive Action Basics".
Related GMP News
21.01.2025FDA Warning Letter Statistics on Medical Devices in the past Fiscal Year
21.01.2025Artificial Intelligence in Medical Devices - Notified Bodies' Point of View
21.01.2025New FDA Guidance on Risk Analyses for Drugs, Biologics and Combination Products
08.10.2024EMA updates Question and Answer Document on Combination Products
08.10.2024Transparency Guidelines for Medical Devices with Artificial Intelligence
12.09.2024Notified Body Survey on Certificates & Applications under the Medical Devices/IVD Regulation